Skip to main content
YESCARTA is a prescription medicine used to treat large B-cell lymphoma, a type of non-Hodgkin lymphoma, when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer. YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells Read Less

Resources & Support

You’re not in this alone. We have experienced people and useful resources ready to help, no matter what stage of the journey you’re in.

Kite Mentor Match

Connect with someone who truly understands

The Kite Mentor Match program pairs you with a patient or caregiver who has experience with large B-cell lymphoma and CAR T-cell therapy.

One-on-One

A real YESCARTA patient or caregiver talks you through the treatment experience by phone in the comfort of your own home.

Secure and Confidential

All calls are facilitated through a secure dial-in and are confidential, with no personal information shared between you and your mentor aside from your first names.


Find a Mentor

Call Kite Mentor Match to connect with a patient or caregiver mentor:
1-844-718-6800, Monday–Friday, 5 am–6 am PT.

Available for patients who have had 2 or more treatments that failed to control their cancer.

Downloadable resources

The YESCARTA Patient Brochure

has a wealth of helpful information about YESCARTA, CAR T-cell therapy, and how to get treated.

The YESCARTA Therapy Discussion Tool

contains questions and discussion topics to help guide your next conversation with an oncologist.

The YESCARTA Caregiver Resource Guide

tells caregivers how to help a loved one receiving CAR T-cell therapy.

Additional Resources

Resources and support programs for patients, families, and caregivers may be available through the following organizations:

The organizations listed above are independent from Kite and Gilead, and this list is subject to change. This information is provided as a resource for patients and is not an endorsement or guarantee of assistance.

Kite Konnect® is here to help

You don’t have to do it all on your own. From finding an Authorized Treatment Center, to learning about support resources that may be available to you, Kite Konnect is here to help you and your caregiver throughout the treatment journey once your physician has decided CAR T-cell therapy is appropriate for you.

Patient Navigators

Patient navigators are here to help patients and caregivers feel informed, confident, and supported throughout every step of the CAR T treatment journey.

Reimbursement Support

To assist with understanding coverage for your Kite treatment, help with benefits investigations, claims appeals information, and potential sources of support for eligible uninsured and underinsured patients.

Logistics Support

Kite Konnect can provide information about potential resources for transportation and housing assistance.

Find a Treatment Center

Kite Konnect can help you find a CAR T Authorized Treatment Center when you’re ready to begin therapy.

Please note: Kite Konnect support may be subject to eligibility requirements and other terms and conditions. Contact Kite Konnect for more information.

Authorized Treatment Centers are independent facilities certified to dispense Kite CAR T therapies. Choice of an Authorized Treatment Center is within the sole discretion of the physician and patient. Kite does not endorse any individual treatment sites.

Resources may include referrals to independent third-party nonprofit patient assistance programs. These programs are not operated or controlled by Kite. Nonprofit patient assistance program eligibility requirements may vary and are established solely by each independent organization. Kite makes no guarantee with respect to reimbursement or copay assistance for any item or service.

Cell therapy patient programs are for eligible prescribed patients.

Kite Konnect® can help with finding an Authorized Treatment Center and provide information about the support resources that may be available to you. 1-844-454-KITE [5483], Monday–Friday, 5 am–6 pm PT.

IMPORTANT SAFETY INFORMATION What is the most important information I should know about YESCARTA?

YESCARTA may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

  • Fever (100.4°F/38°C or higher)
  • Difficulty breathing
  • Chills or shaking chills
  • Confusion
  • Dizziness or lightheadedness
  • Severe nausea, vomiting, or diarrhea
  • Fast or irregular heartbeat
  • Severe fatigue or weakness

It is important to tell your healthcare provider that you received YESCARTA and to show them your YESCARTA Patient Wallet Card. Your healthcare provider may give you other medicines to treat your side effects.

Before getting YESCARTA, tell your healthcare provider about all your medical problems, including if you have or have had:

  • Neurologic problems (such as seizures, stroke, or memory loss)
  • Lung or breathing problems
  • Heart problems
  • Liver problems
  • Kidney problems
  • A recent or active infection

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive YESCARTA?

  • Since YESCARTA is made from your own white blood cells, your blood will be collected by a process called “leukapheresis” (loo-kah-fur-ee-sis), which will concentrate your white blood cells.
  • Your blood cells will be sent to a manufacturing center to make your YESCARTA.
  • Before you get YESCARTA, you will get 3 days of chemotherapy to prepare your body.
  • When your YESCARTA is ready, your healthcare provider will give it to you through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes.
  • You will be monitored where you received your treatment daily for at least 7 days after the infusion.
  • You should plan to stay close to the location where you received your treatment for at least 4 weeks after getting YESCARTA. Your healthcare provider will help you with any side effects that may occur.
  • You may be hospitalized for side effects and your healthcare provider will discharge you if your side effects are under control, and it is safe for you to leave the hospital.
  • Your healthcare provider will want to do blood tests to follow your progress. It is important that you do have your blood tested. If you miss an appointment, call your healthcare provider as soon as possible to reschedule.

What should I avoid after receiving YESCARTA?

  • Do not drive, operate heavy machinery, or do other dangerous things for 8 weeks after you get YESCARTA because the treatment can cause sleepiness, confusion, weakness, and temporary memory and coordination problems.
  • Do not donate blood, organs, tissues, or cells for transplantation.

What are the possible or reasonably likely side effects of YESCARTA?

The most common side effects of YESCARTA include:

  • Fever (100.4°F/38°C or higher)
  • Low white blood cells (can occur with a fever)
  • Low red blood cells
  • Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath)
  • Fast heartbeat
  • Confusion
  • Difficulty speaking or slurred speech
  • Nausea
  • Diarrhea

These are not all the possible side effects of YESCARTA. Call your healthcare provider about any side effects that concern you. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

Please see the Important Facts, including IMPORTANT WARNINGS.

APPROVED USE

YESCARTA is a prescription medicine used to treat large B-cell lymphoma, a type of non-Hodgkin lymphoma, when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer. YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.